News and applications for life science research professionals
Subscribe to Bioscience Technology All

The Lead

NYC Tries to Ease Ebola Fear After Doctor Infected

October 24, 2014 | by Jonathan Lemire and Colleen Long - Associated Press - Associated Press | News | Comments

Officials tried to tamp down New Yorkers' fears Friday after a doctor was diagnosed with Ebola in a city where millions of people squeeze into crowded subways, buses and elevators every day.                 

View Sample

FREE Email Newsletter Bioscience Technology Daily

Hepatitis B Reagents

October 24, 2014 11:41 am | Product Releases | Comments

ViroStat has expanded its offering of hepatitis B reagents including its MONOTOPE and OMNITOPE antibodies and Recombinant Antigens.

Proteins Direct Precursors of Pyramidal Cells to Their Destination

October 24, 2014 11:26 am | News | Comments

Researchers have now discovered that FLRT proteins on the surface of progenitor cells can induce repellent and attractant signals depending on its binding partner.                         


New Weight Loss Regulation Clues Discovered

October 24, 2014 11:18 am | News | Comments

A hormone seen as a popular target to develop weight loss drugs works by directly targeting the brain and triggering previously unknown activity in the nervous system, obesity researchers have found.                


Thyroid Cancer Genome Analysis Finds Markers of Aggressive Tumors

October 24, 2014 10:21 am | News | Comments

A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.       


Scientists ID Gene Required for Recovery from Bacterial Infection

October 24, 2014 10:07 am | News | Comments

Researchers have uncovered the genes that are normally activated during recovery from bacterial infection. The finding could lead to ways to jumpstart this recovery process and possibly fend off autoimmune diseases and chronic inflammatory disorders.


Beds at Ebola treatment units empty in Liberia

October 24, 2014 8:26 am | by Jonathan Paye-layleh - Associated Press - Associated Press | News | Comments

Even as Liberians fall ill and die of Ebola, many beds in treatment centers are empty because of the government's order that the bodies of all suspected Ebola victims in the capital be cremated, authorities have determined. Cremation violates values and cultural practices in the western African...

Doctors Without Borders: Ebola risk can't be zero

October 24, 2014 8:26 am | by Boubacar Diallo - Associated Press - Associated Press | News | Comments

Doctors Without Borders says that while it takes measures to protect its staff treating Ebola patients, the risk of contagion cannot be entirely eliminated. Craig Spencer, an American doctor who worked with the aid organization in Guinea, is being treated for the disease in New York. An official...

Pakistan detects more polio cases on awareness day

October 24, 2014 8:26 am | by The Associated Press | News | Comments

World Health Organization says three more polio cases have surfaced in Pakistan, bringing the number of those affected by the crippling disease in the country this year to 220. The statement came as many nations observed World Polio Day on Friday to create awareness about polio. Pakistan,...


Official cites 'epidemic of fear' in US

October 24, 2014 4:25 am | by Erica Werner - Associated Press - Associated Press | News | Comments

The likelihood of a significant outbreak of Ebola in the U.S. is remote, in the view of a top Health and Human Services official who is assuring lawmakers that government agencies are preparing for any contingency. The comments on Ebola from Dr. Nicole Lurie, assistant HHS secretary for...

Ebola cases could spur lawsuits _ with big hurdles

October 24, 2014 2:26 am | by Matt Sedensky - Associated Press - Associated Press | News | Comments

In a land of lawsuits, this case seems made for litigation: A doctor appears to miss a red flag, an Ebola diagnosis is delayed, and a patient dies. But this is Texas. It may not matter much that Texas Health Presbyterian Hospital Dallas apologized for initially misdiagnosing Thomas Eric Duncan,...

Cloning whistle-blower: little change in S. Korea

October 24, 2014 1:24 am | by Youkyung Lee - Associated Press - Associated Press | News | Comments

CHUNCHEON, South Korea (AP) — The whistle-blower who exposed breakthrough cloning research as a devastating fake says South Korea is still dominated by the values that allowed science fraudster Hwang Woo-suk to become an almost untouchable national hero. In an interview with The Associated Press...

NY doctor back from Guinea has Ebola, 1st in city

October 23, 2014 11:25 pm | by Jonathan Lemire - Associated Press - Associated Press | News | Comments

An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus, becoming the first case in the city and the fourth in the nation. Mayor Bill de Blasio and Gov. Andrew Cuomo on Thursday urged residents not to be alarmed by...

Obama looks to inventors for ways to fight Ebola

October 23, 2014 6:25 pm | by Jim Kuhnhenn - Associated Press - Associated Press | News | Comments

President Barack Obama is looking for a few smart ideas from the science and technology fields that could help address the challenge posed by Ebola. Obama met with members of his Council of Advisers on Science and Technology on Thursday, looking to tap into the world of inventors and innovators...

NPS Pharma says FDA extends review of Natpara

October 23, 2014 5:25 pm | by The Associated Press | News | Comments

NPS Pharmaceuticals says the Food and Drug Administration won't make a decision on its drug Natpara on Friday and will extend its review by three months. The company said Thursday that the FDA is now scheduled to make a decision on Natpara by Jan. 24. NPS said the FDA wants more time to review...

Celgene 3Q profit climbs; company lifts outlook

October 23, 2014 3:26 pm | by The Associated Press | News | Comments

Celgene Corp. said Thursday that its net income climbed 37 percent in the third quarter, and the biotechnology company raised its forecast for the full year. Celgene also announced a new cancer drug development partnership with a price tag that could top $1 billion. Its shares gained $5.84, or...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.